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Background
Amyloid deposition of Ab peptide characterizes AD. Ab
derives from sequential cleavage of APP by b-a n d
g-secretases. Interestingly, mutations in either APP or
the g-secretase genes PSEN1/2 cause familial AD (FAD).
Mutation of BRI2/ITM2b causes an AD-like familial
dementia (FDD) with amyloid deposits. The FDD pla-
ques contain Ab and ADan, which derives from proces-
sing of mutant BRI2 protein by pro-protein convertases.
Since amyloidogenic peptides are believed to cause
dementias, transgenic mice carrying mutant APP,
PSEN1/2 or BRI2/ITM2b are used to model these
dementias, as over-expression is necessary to reproduce
amyloidosis. However, over-expression of mutant genes
might produce harmful effects unrelated to dementias
and lead to erroneous information concerning pathogen-
esis and therapy of human diseases. The clinical failures
of compounds efficacious in transgenic models support
this hypothesis.
Methods
To avoid artifacts of over-expression, we generated a
knock-in mouse model of FDD (FDDKI) that, like FDD
patients, is heterozygous for one mutated FDD allele of
BRI2/ITM2b.F D D KI mice develop progressive synaptic
and memory deficits due to loss of Bri2 function, with no
amyloidosis and tauopathy. BRI2 binds APP and inhibits
APP processing; owing to the loss of BRI2, APP processing
is increased in FDD. Remarkably, memory deficits of
FDDKI mice require APP, providing genetic evidence that
APP and BRI2 functionally interact, and that APP med-
iates FDD neuropathology.
Results
APP processing is genetically linked to AD pathogenesis,
which is consistent with a common mechanism involving
toxic APP metabolites in both dementias and prompts
the question whether blocking APP processing amelio-
rates FDD. Here we show that either a BRI2-derived pep-
tide that, like BRI2, binds APP and blocks its cleavage by
b-secretase, or a b-secretase inhibitor, rescues synaptic
and memory deficits of FDDKI mice. b-cleavage of APP
yields two metabolites, amino terminal soluble APPb
(sAPPb)a n db-carboxyl terminal fragment (b-CTF).
Further processing of b-CTF by g-secretase cleavage
releases amyloid-b, which is reputed to be central to AD
pathophysiology. Intriguingly however, inhibition of
g-secretase did not ameliorate the synaptic and memory
deficits of FDD mice.
Conclusions
This result demonstrates that APP proteolysis triggers
FDD, and establishes the importance of b-processing of
APP for dementia to occur. Moreover, the data indicated
instead that sAPPb and/or b-CTF, rather than amyloid-b,
are the toxic species causing dementia. This suggests that
reducing b-cleavage of APP is an appropriate therapeutic
approach to treating human dementias, while discouraging
targeting g-secretase cleavage of APP and/or amyloid-b.
The recurring failures of anti-amyloid-b therapies in
humans are consistent with this hypothesis.
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